Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial-Reference-Cited by-同舟云学术

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

Published:2015-07 Issue:9990 Volume:386 Page:249-257
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kehoe Sean,Hook Jane,Nankivell Matthew,Jayson Gordon C,Kitchener Henry,Lopes Tito,Luesley David,Perren Timothy,Bannoo Selina,Mascarenhas Monica,Dobbs Stephen,Essapen Sharadah,Twigg Jeremy,Herod Jonathan,McCluggage Glenn,Parmar Mahesh,Swart Ann-Marie

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J Clin Oncol,2002

2. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

3. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma;Griffiths;Natl Cancer Inst Monogr,1975

4. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data;Polterauer;Int J Gynecol Cancer,2012

5. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer;van der Burg;N Engl J Med,1995

Cited by 1080 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer;Neoplasia;2024-11

2. Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes;Cancers;2024-09-03

3. The clinical importance of IFN-γ and human epididymis protein 4 in Egyptian patients with epithelial ovarian cancer combined with HPV infection;Human Immunology;2024-09

4. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

5. The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis;European Journal of Surgical Oncology;2024-09